Biosensors (B20.SG) +17.2% at $0.985, highest level since January 2008, on robust volume. Interest piqued by two bullish broker reports, according to Dow Jones.
Nomura, which has Buy call with $1.20 target, flags next week’s Hong Kong listing of MicroPort Scientific, which makes equipment for keyhole surgery, as catalyst for Singapore heart-stent maker.
Biosensors (B20.SG) is down 1.3% at $0.785, extending Thursday’s 1.2% fall, as investors continue to unload shares following release of heart-stent maker’s fiscal FY10 results late last week, according to Dow Jones.
Biosensors (B20.SG) has gained 1.9% at 79.5 cents in active trade as investors relook at stock after 8.2% fall since beginning March, reported Dow Jones Newswires.
Recent weakness triggered partly by concerns over heart stent maker’s distribution business in Germany following Medtronics’ acquisition of Invatec, an affiliate Krauth Cardiovascular, which distributes Biosensors’ flagship BioMatrix stent in Germany, one of Europe’s major stent markets.
